These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26404254)

  • 41. Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment.
    Aqul A; Liu B; Ramirez CM; Pieper AA; Estill SJ; Burns DK; Liu B; Repa JJ; Turley SD; Dietschy JM
    J Neurosci; 2011 Jun; 31(25):9404-13. PubMed ID: 21697390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin.
    Maulik M; Ghoshal B; Kim J; Wang Y; Yang J; Westaway D; Kar S
    Hum Mol Genet; 2012 Nov; 21(22):4857-75. PubMed ID: 22869680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracellular trafficking of cholesterol monitored with a cyclodextrin.
    Neufeld EB; Cooney AM; Pitha J; Dawidowicz EA; Dwyer NK; Pentchev PG; Blanchette-Mackie EJ
    J Biol Chem; 1996 Aug; 271(35):21604-13. PubMed ID: 8702948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The immunologic outcome of enhanced function of mouse liver lymphocytes and Kupffer cells by high-fat and high-cholesterol diet.
    Shono S; Habu Y; Nakashima M; Sato A; Nakashima H; Miyazaki H; Kinoshita M; Tsumatori G; Shinomiya N; Seki S
    Shock; 2011 Nov; 36(5):484-93. PubMed ID: 21937954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
    Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
    Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic treatment with bark infusion from Croton cajucara lowers plasma triglyceride levels in genetic hyperlipidemic mice.
    Bighetti EJ; Souza-Brito AR; de Faria EC; Oliveira HC
    Can J Physiol Pharmacol; 2004 Jun; 82(6):387-92. PubMed ID: 15381962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice.
    Hovakimyan M; Maass F; Petersen J; Holzmann C; Witt M; Lukas J; Frech MJ; Hübner R; Rolfs A; Wree A
    Neuroscience; 2013 Nov; 252():201-11. PubMed ID: 23948640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel transgenic mouse model of lysosomal storage disorder.
    Ortiz-Miranda S; Ji R; Jurczyk A; Aryee KE; Mo S; Fletcher T; Shaffer SA; Greiner DL; Bortell R; Gregg RG; Cheng A; Hennings LJ; Rittenhouse AR
    Am J Physiol Gastrointest Liver Physiol; 2016 Nov; 311(5):G903-G919. PubMed ID: 27659423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis.
    Zhang Y; Gong F; Wu Y; Hou S; Xue L; Su Z; Zhang C
    Nano Lett; 2021 Nov; 21(22):9736-9745. PubMed ID: 34748340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.
    Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH
    Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory "Prodrug".
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2016 Jun; 19(3):252-5. PubMed ID: 27241174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells.
    Motoyama K; Nishiyama R; Maeda Y; Higashi T; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Beilstein J Org Chem; 2017; 13():10-18. PubMed ID: 28179943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.
    Sidhu R; Jiang H; Farhat NY; Carrillo-Carrasco N; Woolery M; Ottinger E; Porter FD; Schaffer JE; Ory DS; Jiang X
    J Lipid Res; 2015 Jun; 56(6):1222-33. PubMed ID: 25866316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases.
    Megías-Vericat JE; García-Robles A; Company-Albir MJ; Fernández-Megía MJ; Pérez-Miralles FC; López-Briz E; Casanova B; Poveda JL
    Neurol Sci; 2017 May; 38(5):727-743. PubMed ID: 28155026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effect.
    Scantlebery AML; Ochodnicky P; Kors L; Rampanelli E; Butter LM; El Boumashouli C; Claessen N; Teske GJ; van den Bergh Weerman MA; Leemans JC; Roelofs JJTH; Florquin S
    Sci Rep; 2019 Nov; 9(1):17633. PubMed ID: 31776357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
    Funk RS; Krise JP
    Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.